March 17, 2020 / 12:42 AM / 23 days ago

BRIEF-Cansino Biologics Says Co & Institute Of Biotechnology, Academy Of Military Medical Sciences Jointly Developing Recombinant Novel Coronavirus Vaccine

March 17 (Reuters) - Cansino Biologics Inc:

* CO & INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES JOINTLY DEVELOPING RECOMBINANT NOVEL CORONAVIRUS VACCINE

* JOINT DEVELOPERS SUBMITTED PRE-INVESTIGATIONAL NEW DRUG REVIEW APPLICATION FOR AD5-NCOV TO REGULATORY AUTHORITIES

* INITIATED PREPARATION FOR CLINICAL TRIALS AND PRE-SCREENING OF VOLUNTEERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below